/

Empresas

Nu

No verificado

Nucleix

Sobre qué escribimos

BiotecnologíaIndustriaMedicina - VariosOncologíaSalud

4 Comunicados de prensa

Ver todos los comunicados de prensa

16/12/2025

Industria

Oncología

Salud

Material médico sanitario

Medicina - Varios

Ciencia

Biotecnología

A Study Published in European Urology Oncology Demonstrated Bladder EpiCheck® Can Detect High-Grade Bladder Cancer Recurrences Missed by White Light Cystoscopy

Fuente

Editor

1.00

0

25/04/2025

Biotecnología

Salud

Oncología

Material médico sanitario

Nucleix to Present Data Showcasing Performance and Clinical Utility of Bladder EpiCheck® Monitoring in Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence at AUA 2025

Fuente

Editor

1.00

0

25/03/2025

Eventos

Industria

Biotecnología

Salud

Oncología

NHS Lothian and Nucleix Presented Data at EAU25 Showcasing Potential of Bladder EpiCheck® to Improve Detection of Disease Recurrence in Non-Muscle Invasive Bladder Cancer (NMIBC) Patients

Fuente

Editor

1.00

0

09/09/2024

Multimedia

Mercado laboral

Industria

Oncología

Salud

Sanidad

Medicina - Varios

Farmacéutica

Biotecnología

A. Menarini Diagnostics and Nucleix Announce a Strategic Partnership for a Non-Invasive Bladder Cancer Test in Europe

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0